Related Experiment Video
Updated: Sep 30, 2025

13:00
Engineering Antiviral Agents via Surface Plasmon Resonance
Published on: June 14, 2022
2.5K
Structural basis for HCMV Pentamer receptor recognition and antibody neutralization
Marc Kschonsak1, Matthew C Johnson1, Rachel Schelling2
1Department of Structural Biology, Genentech Inc., South San Francisco, CA 94080, USA.
Science Advances
|March 11, 2022
Summary
Human cytomegalovirus (HCMV) uses its Pentamer complex to infect cells. This study reveals the structures of Pentamer bound to cellular receptors, offering insights into viral entry and antibody neutralization for vaccine development.
Area of Science:
- Virology
- Structural Biology
- Immunology
Background:
- Human cytomegalovirus (HCMV) is a major cause of congenital birth defects.
- The HCMV Pentamer complex (gH/gL/UL128-130-131A) mediates viral entry into epithelial and endothelial cells.
- The Pentamer elicits potent neutralizing antibody responses, making it a crucial vaccine target, but its structural basis for receptor interaction and neutralization is poorly understood.
Purpose of the Study:
- To elucidate the structural mechanisms of HCMV Pentamer engagement with cellular receptors.
- To understand how neutralizing antibodies interact with the Pentamer complex.
- To identify novel functional receptors for HCMV and characterize their interaction with the Pentamer.
Main Methods:
- X-ray crystallography to determine the structures of the HCMV Pentamer complex.
- Complex formation with cellular receptors Neuropilin 2 (NRP2) and Thrombomodulin (THBD).
- Structural analysis of Pentamer-antibody complexes.
Main Results:
- Determined structures of the HCMV Pentamer bound to NRP2 and neutralizing antibodies.
- Identified Thrombomodulin (THBD) as a functional HCMV receptor and determined the Pentamer-THBD complex structure.
- Observed that both NRP2 and THBD induce dimerization of the Pentamer complex.
Conclusions:
- Provides a structural framework for understanding HCMV receptor recognition and cell entry mechanisms.
- Offers insights into antibody neutralization of HCMV.
- Outlines potential strategies for developing novel antiviral therapies against HCMV infections.

